Effect of continuous blood purification on endothelial cell function in patients with severe sepsis

Chinese Critical Care Medicine

Volumn 23, Issue 2, 2011, Pages 81-84

  Han, Sha Sha ^a   Sun, Ting ^a   Li, Zhi ^a   Jia, Ling Zhi ^a   Shang, Quan Mei ^a   Wang, Xiao Zhi ^a  

^a BINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Continuous blood purification; Endothelial cell; Severe sepsis

Indexed keywords

ACTIVATED PROTEIN C; INTERCELLULAR ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

APACHE; ARTICLE; BLOOD GAS ANALYSIS; CELL FUNCTION; CONTINUOUS BLOOD PURIFICATION; CONTINUOUS HEMOFILTRATION; CONTINUOUS VENO VENOUS HEMOFILTRATON; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIUM CELL; HOSPITALIZATION; HUMAN; HUMAN CELL; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MORTALITY; PRACTICE GUIDELINE; SEPSIS; TREATMENT OUTCOME;

ADULT; AGED; ENDOTHELIAL CELLS; FEMALE; HEMOFILTRATION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; PROGNOSIS; PROTEIN C; SEPSIS; VON WILLEBRAND FACTOR;

EID: 79952796688     PISSN: 10030603     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1003-0603.2011.02.006     Document Type: Article

References (15)

1. Aird WC. Endothelium as a therapeutic target in sepsis. Curr Drug Targets, 2007,8:501-507. (Pubitemid 46672617)
2. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med, 2003,31:1250-1256.
3. Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock : 2008. Intensive Care Med, 2008,34: 17-60.
4. Bouman CS, Oudemans-van Straaten HM, Schultz MJ, et al. Hemofiltration in sepsis and systemic inflammatory response syndrome: the role of dosing and timing. J Crit Care, 2007,22: 1-12. (Pubitemid 46420754)
5. Honore PM, Jamez J, Wauthier M, et al. Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med, 2000,28:3581-3587.
6. Annane D, Aegerter P, Jars-Guincestre MC et al. Current epidemiology of septic shock: the CUB-Réa Network. Am J Respir Crit Care Med, 2003,168:165-172. (Pubitemid 36920969)
7. Mutunga M, Fulton B, Bullock R, et al. Circulating endothelial cells in patients with septic shock. Am J Respir Crit Care Med, 2001,163:195-200. (Pubitemid 32095270)
8. Ware LB, Conner ER, Matthay MA. von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury. Crit Care Med, 2001,29:2325-2331.
9. Sessler CN, Windsor AC, Schwartz M, et al. Circulating ICAM-1 is increased in septic shock. AM J Respir Crit Care Med, 1995,151:1420-1427.
10. Reed JC. Proapoptotic multidomain Bcl-2/Bax-family proteins, mechanisms, physiological roles, and therapeutic opportunities. Cell Death Differ, 2006,13:1378-1386. (Pubitemid 44057473)
11. Finigan JH, Dudek SM, Singleton PA, et al. Activated protein C mediates novel lung endothelial barrier enhancement : role of sphingosine 1-phosphate receptor transactivation. J Biol Chem, 2005,280:17286-17293. (Pubitemid 41389197)